srk-181
scholar
['advance', 'dragon', 'ca,022,1', 'ca,022,i', 'marker ']
 #sitc2022 abstract 780 srk-181, a latent #tgf 1 inhibitor: safety, efficacy, and biomarker results from the dose escalation portion of a phase i trial (dragon trial) in patients with advanced solid tumors/ #drugdevelopment 